This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chen, C-Y Articles by Huang, J-L Search for Related Content PubMed PubMed Citation Articles by Chen, C-Y Articles by Huang, J-L Social Bookmarking                         What's this?

Use of a new fluorescence immunoassay to detect anti-dsDNA antibodies is more correlated with disease activity and complement than the ELISA method in SLE patients

Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, and Chang Gung University, Taoyuan, Taiwan, Republic of China, Department of Pediatrics, Ton Yen General Hospital, Chu Pei, Hsinchu, Taiwan, Republic of China

H-M Tseng

Department of Healthcare Management, Chang Gung University, Taoyuan, Taiwan, Republic of China

L-C Chen

Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, and Chang Gung University, Taoyuan, Taiwan, Republic of China

C-H Tsao

Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, and Chang Gung University, Taoyuan, Taiwan, Republic of China, Department of Pediatrics, St. Paul’s Hospital, Taoyuan, Taiwan, Republic of China

M-L Kuo

Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, and Chang Gung University, Taoyuan, Taiwan, Republic of China

L-S Ou

Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, and Chang Gung University, Taoyuan, Taiwan, Republic of China

J-L Huang

Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, and Chang Gung University, Taoyuan, Taiwan, Republic of China, long{at}adm.cgmh.org.tw

To determine whether the serum levels of anti-double strand DNA (anti-dsDNA) autoantibodies detected using a newly developed fluorescence immunoassay (FIA) in patients with systemic lupus erythematosus (SLE) correlated more with clinical parameters, such as SLE disease activity index (SLEDAI), complement and the occurrence of nephritis when compared with traditional enzyme-linked immunosorbent assay (ELISA), we prospectively collected 124 serum samples from 31 patients who had juvenile-onset SLE and were regularly monitored every 2 months at our outpatient clinic. At every visit, clinical manifestations and laboratory parameters were assessed and the SLEDAI was determined. Correlation analyses between the two different measurements of anti-dsDNA antibodies and SLEDAI, serum complement levels and the occurrence of nephritis were performed. The results showed that anti-dsDNA autoantibodies detected using both ELISA and FIA significantly correlated with SLEDAI, and significantly and inversely correlated with the serum levels of C3 and C4. FIA had significantly higher correlation with SLEDAI and C4 than did ELISA. The mean values of anti-dsDNA antibodies detected using FIA in patients with nephritis were significantly higher than in those without nephritis. In contrast, the values of anti-dsDNA antibodies detected using ELISA did not show significant differences between these two groups. We conclude that FIA had better correlationwith SLEDAI, C4 and the occurrenceof nephritis, and comparable correlationswith C3 that were similar to the results found using ELISA. Thus, it is worthwhile developing the FIA method for clinical evaluation of disease activity in SLE patients.

Key Words: systemic lupus erythematosus • autoantibody • double-stranded DNA • fluorescence immunoassay • enzyme-linked immunosorbent assay (ELISA)

Lupus, Vol. 12, No. 4, 266-273 (2003)
DOI: 10.1191/0961203303lu331oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H-P Jaekel, A Trabandt, N Grobe, and E Werle Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis Lupus, June 1, 2006; 15(6): 335 - 345. [Abstract] [PDF]

				M Lopez-Hoyos, R Cabeza, V M Martinez-Taboada, J Crespo, D SanSegundo, R Blanco, H Lopez-Escribano, M Pena, and V Rodriguez-Valverde Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus Lupus, July 1, 2005; 14(7): 505 - 509. [Abstract] [PDF]

				J. Verma, V. Arora, V. Marwaha, A. Kumar, and N. Das Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus Lupus, April 1, 2005; 14(4): 273 - 279. [Abstract] [PDF]

				M Lopez-Hoyos, I Ayerbe, V M Martinez-Taboada, M J Bartolome, R Blanco, H Lopez-Escribano, M Pena, and V Rodriguez-Valverde Letter to the Editor Lupus, February 1, 2004; 13(2): 144 - 147. [PDF]